These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23403056)

  • 1. The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011.
    Kremers MS; Hammill SC; Berul CI; Koutras C; Curtis JS; Wang Y; Beachy J; Blum Meisnere L; Conyers del M; Reynolds MR; Heidenreich PA; Al-Khatib SM; Pina IL; Blake K; Norine Walsh M; Wilkoff BL; Shalaby A; Masoudi FA; Rumsfeld J
    Heart Rhythm; 2013 Apr; 10(4):e59-65. PubMed ID: 23403056
    [No Abstract]   [Full Text] [Related]  

  • 2. Performance and survival of transvenous defibrillation leads: need for a European data registry.
    Goette A; Cantu F; van Erven L; Geelen P; Halimi F; Merino JL; Morgan JM;
    Europace; 2009 Jan; 11(1):31-4. PubMed ID: 19004838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective long-term evaluation of Optim-insulated (Riata ST Optim and Durata) implantable cardioverter-defibrillator leads.
    Cairns JA; Epstein AE; Rickard J; Connolly SJ; Buller C; Wilkoff BL; Pogue J; Themeles E; Healey JS
    Heart Rhythm; 2014 Dec; 11(12):2156-62. PubMed ID: 25131665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute lead dislodgements and in-hospital mortality in patients enrolled in the national cardiovascular data registry implantable cardioverter defibrillator registry.
    Cheng A; Wang Y; Curtis JP; Varosy PD
    J Am Coll Cardiol; 2010 Nov; 56(20):1651-6. PubMed ID: 21050975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of implantable cardioverter-defibrillator leads: a matter of lead size?
    Rordorf R; Poggio L; Savastano S; Vicentini A; Petracci B; Chieffo E; Klersy C; Landolina M
    Heart Rhythm; 2013 Feb; 10(2):184-90. PubMed ID: 23063430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of the ICD Registry's third year, expansion to include lead data and pediatric ICD procedures, and role for measuring performance.
    Hammill SC; Kremers MS; Kadish AH; Stevenson LW; Heidenreich PA; Lindsay BD; Mirro MJ; Radford MJ; McKay C; Wang Y; Lang CM; Pontzer K; Rumsfeld J; Phurrough SE; Curtis JP; Brindis RG
    Heart Rhythm; 2009 Sep; 6(9):1397-401. PubMed ID: 19716099
    [No Abstract]   [Full Text] [Related]  

  • 7. Permanent pacemakers and implantable defibrillators: considerations for intensivists.
    McPherson CA; Manthous C
    Am J Respir Crit Care Med; 2004 Nov; 170(9):933-40. PubMed ID: 15297272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization trends and clinical outcomes in patients implanted with a single- vs a dual-coil implantable cardioverter-defibrillator lead: Insights from the ALTITUDE Study.
    Hsu JC; Saxon LA; Jones PW; Wehrenberg S; Marcus GM
    Heart Rhythm; 2015 Aug; 12(8):1770-5. PubMed ID: 25916569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes in patients with implantable cardioverter defibrillators and Sprint Fidelis leads.
    Verlato R; Facchin D; Catanzariti D; Molon G; Zanotto G; Morani G; Brieda M; Zanon F; Delise P; Leoni L; Comisso J; Campo C
    Heart; 2013 Jun; 99(11):799-804. PubMed ID: 23434626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
    Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M;
    Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival after implantable cardioverter-defibrillator implantation in the elderly.
    Yung D; Birnie D; Dorian P; Healey JS; Simpson CS; Crystal E; Krahn AD; Khaykin Y; Cameron D; Chen Z; Lee DS
    Circulation; 2013 Jun; 127(24):2383-92. PubMed ID: 23775193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Italian Implantable Cardioverter-Defibrillator Registry. A survey of the national activity during the years 2001-2003.
    Proclemer A; Ghidina M; Cicuttini G; Gregori D; Fioretti PM
    Ital Heart J; 2005 Mar; 6(3):272-80. PubMed ID: 15875520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-dependent risk of Fidelis lead failure.
    Faulknier BA; Traub DM; Aktas MK; Aguila A; Rosero S; Daubert JP; Hall B; Shah A; Taylor S; McNitt S; Moss AJ; Zareba W; Huang DT
    Am J Cardiol; 2010 Jan; 105(1):95-9. PubMed ID: 20102898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Sprint Fidelis implantable cardioverter-defibrillator (ICD) leads (Medtronic, Inc., Minneapolis, MN, USA) were removed from the market in October 2007 because of the rate of pace-sense conductor fractures.
    Arias MA; Puchol A; Castellanos E; Pachón M
    Heart Rhythm; 2009 Jan; 6(1):e6-7; author reply e7. PubMed ID: 19121790
    [No Abstract]   [Full Text] [Related]  

  • 15. Simpler is better? Full circle in our attempt to decrease cardioverter defibrillator inappropriate shocks in the young.
    Kugler JD
    J Cardiovasc Electrophysiol; 2009 Mar; 20(3):291-2. PubMed ID: 19175844
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictors affecting durability of epicardial pacemaker leads in pediatric patients.
    Murayama H; Maeda M; Sakurai H; Usui A; Ueda Y
    J Thorac Cardiovasc Surg; 2008 Feb; 135(2):361-6. PubMed ID: 18242269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midterm experience with implantable cardioverter-defibrillators in children and young adults.
    Çeliker A; Olgun H; Karagoz T; Özer S; Özkutlu S; Alehan D
    Europace; 2010 Dec; 12(12):1732-8. PubMed ID: 20852288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A changing scenario in the clinical use of implantable defibrillators: the need for long-term data on lead performance.
    Boriani G; Biffi M; Marziali A; Diemberger I; Martignani C
    Europace; 2009 Jan; 11(1):1-3. PubMed ID: 19088360
    [No Abstract]   [Full Text] [Related]  

  • 19. Do abandoned leads pose risk to implantable cardioverter-defibrillator patients?
    Glikson M; Suleiman M; Luria DM; Martin ML; Hodge DO; Shen WK; Bradley DJ; Munger TM; Rea RF; Hayes DL; Hammill SC; Friedman PA
    Heart Rhythm; 2009 Jan; 6(1):65-8. PubMed ID: 19121802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07.
    Proclemer A; Ghidina M; Gregori D; Facchin D; Rebellato L; Fioretti P; Brignole M
    Europace; 2009 Apr; 11(4):465-75. PubMed ID: 19136490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.